βEnd-to-end visibility and going beyond metrosβ are key priorities for strengthening biopharma supply chains, said Dr. Chandan Shirbhayye, VP and Head of Supply Chain and Operational Excellence at Aragen Life Sciences, during the first business session at the GPLS 2026.
